SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Envoy Medical, (COCH) — Feb 9, 2026

Envoy Medical, Inc.
Date: Feb. 9, 2026 · CIK: 0001840877 · Accession: 0001213900-26-013896

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292260

Date
February 9, 2026
Author
H.C. WAINWRIGHT & CO., LLC
Form
CORRESP
Company
Envoy Medical, Inc.

Letter

Re: Envoy Medical, Inc.

February 9, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549

Registration Statement on Form S-1, as amended

File No. 333-292260

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC ("Wainwright"), as placement agent on a best-efforts basis, hereby joins Envoy Medical, Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1, as amended (File No. 333-292260) (the "Registration Statement"), to become effective on Tuesday, February 10, 2026, at 5:15 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 February 9, 2026

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street NE

 Washington, D.C. 20549

 Re:
 Envoy Medical, Inc.

 Registration Statement on Form S-1, as amended

 File No. 333-292260

 Ladies and Gentlemen:

 In accordance with Rule 461
under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC ("Wainwright"),
as placement agent on a best-efforts basis, hereby joins Envoy Medical, Inc. in requesting that the Securities and Exchange Commission
take appropriate action to cause the Registration Statement on Form S-1, as amended (File No. 333-292260) (the "Registration Statement"),
to become effective on Tuesday, February 10, 2026, at 5:15 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms
that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration
Statement.

 Very truly yours,

 H.C. WAINWRIGHT & CO., LLC

 By:
 /s/ Edward Silvera

 Name:
 Edward Silvera

 Title:
 Co-Chief Executive Officer